Home > Products > Biosimilars

BioSIM anti-Human TNFSF2/TNFa Antibody (Golimumab Biosimilar), Research Grade

Catalog: SIM0346
Cost advantage to: SIM0064
Isotype: IgG1-kappa
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic biosimilar shares the same variable regions as therapeutic Golimumab, ideal for research. It reacts with human TNFα (a multifunctional proinflammatory cytokine existing as soluble 17 kDa monomer/homotrimers or 26 kDa membrane-bound form, key in biological processes and diseases). Golimumab binds TNFα to neutralize it, treating arthritis etc. This biosimilar aids TNFα research and anti-TNF therapy modeling.
 

Specifications

Product Name BioSIM anti-Human TNFSF2/TNFa Antibody (Golimumab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG1-kappa
Target TNFSF2/TNFa
Other Names CNTO148, CAS: 476181-74-5
CAS 476181-74-5
Reactivity Human
Host Species Human
Background This non-therapeutic biosimilar shares the same variable regions as therapeutic Golimumab, ideal for research. It reacts with human TNFα (a multifunctional proinflammatory cytokine existing as soluble 17 kDa monomer/homotrimers or 26 kDa membrane-bound form, key in biological processes and diseases). Golimumab binds TNFα to neutralize it, treating arthritis etc. This biosimilar aids TNFα research and anti-TNF therapy modeling.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products